Related references
Note: Only part of the references are listed.Aspects of Nanotechnology for COVID-19 Vaccine Development and Its Delivery Applications
Pranav Kumar Prabhakar et al.
PHARMACEUTICS (2023)
In vitro degradation and erosion behavior of commercial PLGAs used for controlled drug delivery
Jennifer Walker et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2023)
Representation of molecules for drug response prediction
Xin An et al.
BRIEFINGS IN BIOINFORMATICS (2022)
Neurodegenerative disorders management: state-of-art and prospects of nano-biotechnology
Raj Kumar et al.
CRITICAL REVIEWS IN BIOTECHNOLOGY (2022)
Enhancing preclinical drug discovery with artificial intelligence
R. S. K. Vijayan et al.
DRUG DISCOVERY TODAY (2022)
Xanthohumol: A Metabolite with Promising Anti-Neoplastic Potential
Hardeep S. Tuli et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2022)
Deep learning tools for advancing drug discovery and development
Sagorika Nag et al.
3 BIOTECH (2022)
Lipid-based nanoparticles for treatment of cancer
Sumit Sheoran et al.
HELIYON (2022)
Prediction of the Ibuprofen Loading Capacity of MOFs by Machine Learning
Xujie Liu et al.
BIOENGINEERING-BASEL (2022)
Nanocarrier vaccines for SARS-CoV-2
Jatin Machhi et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
Phytochemicals in Gynecological Cancer Prevention
Marta Wozniak et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Computational pharmaceutics-A new paradigm of drug delivery
Wei Wang et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Green Synthesis of Gold Nanoparticles Using Plant Extracts as Beneficial Prospect for Cancer Theranostics
Kaushik Kumar Bharadwaj et al.
MOLECULES (2021)
Antioxidant vs. Prooxidant Properties of the Flavonoid, Kaempferol, in the Presence of Cu(II) Ions: A ROS-Scavenging Activity, Fenton Reaction and DNA Damage Study
Miriama Simunkova et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Gene silencing delivery systems for the treatment of pancreatic cancer: Where and what to target next?
David Vetvicka et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Targeted delivery of quercetin by nanoparticles based on chitosan sensitizing paclitaxel-resistant lung cancer cells to paclitaxel
Yonghong Wang et al.
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2021)
Prediction of drug-target binding affinity using similarity-based convolutional neural network
Jooyong Shim et al.
SCIENTIFIC REPORTS (2021)
Toxicity prediction based on artificial intelligence: A multidisciplinary overview
Efren Perez Santin et al.
WILEY INTERDISCIPLINARY REVIEWS-COMPUTATIONAL MOLECULAR SCIENCE (2021)
Novel Approaches to Epigenetic Therapies: From Drug Combinations to Epigenetic Editing
Aleksandra Majchrzak-Celinska et al.
GENES (2021)
A review on compound-protein interaction prediction methods: Data, format, representation and model
Sangsoo Lim et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)
Naringenin Nano-Delivery Systems and Their Therapeutic Applications
Mohammed Bhia et al.
PHARMACEUTICS (2021)
Artificial intelligence to deep learning: machine intelligence approach for drug discovery
Rohan Gupta et al.
MOLECULAR DIVERSITY (2021)
Enhancing Clinical Translation of Cancer Using Nanoinformatics
Madjid Soltani et al.
CANCERS (2021)
Graphene-Based Nanomaterials for Neuroengineering: Recent Advances and Future Prospective
Raj Kumar et al.
ADVANCED FUNCTIONAL MATERIALS (2021)
Bio-Nanocarriers for Lung Cancer Management: Befriending the Barriers
Shruti Rawal et al.
NANO-MICRO LETTERS (2021)
Comprehensive strategies of machine-learning-based quantitative structure-activity relationship models
Jiashun Mao et al.
ISCIENCE (2021)
Big Data and Artificial Intelligence Modeling for Drug Discovery
Hao Zhu
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 60 (2020)
An Overview of Machine Learning and Big Data for Drug Toxicity Evaluation
Andy H. Vo et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2020)
CapsCarcino: A novel sparse data deep learning tool for predicting carcinogens
Yi-Wei Wang et al.
FOOD AND CHEMICAL TOXICOLOGY (2020)
Improved chemotherapeutic efficacy against resistant human breast cancer cells with co-delivery of Docetaxel and Thymoquinone by Chitosan grafted lipid nanocapsules: Formulation optimization, in vitro and in vivo studies
Sobiya Zafar et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2020)
Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice
Amit S. Choudhari et al.
FRONTIERS IN PHARMACOLOGY (2020)
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019
David J. Newman et al.
JOURNAL OF NATURAL PRODUCTS (2020)
Genoprotective activities of plant natural substances in cancer and chemopreventive strategies in the context of 3P medicine
Lenka Koklesova et al.
EPMA JOURNAL (2020)
Potential of nano-phytochemicals in cervical cancer therapy
Neera Yadav et al.
CLINICA CHIMICA ACTA (2020)
The Role of Diet in Cancer Prevention and Chemotherapy Efficacy
Steven D. Mittelman
ANNUAL REVIEW OF NUTRITION, VOL 40, 2020 (2020)
Tumor-responsive dynamic nanoassemblies for targeted imaging, therapy and microenvironment manipulation
Liang Ee Low et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Combination Therapy with Nanomicellar-Curcumin and Temozolomide for In Vitro Therapy of Glioblastoma Multiforme via Wnt Signaling Pathways
Ali Bagherian et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2020)
Machine learning and AI-based approaches for bioactive ligand discovery and GPCR-ligand recognition
Sebastian Raschka et al.
METHODS (2020)
Artificial intelligence in drug discovery and development
Debleena Paul et al.
DRUG DISCOVERY TODAY (2020)
Comparative study between deep learning and QSAR classifications for TNBC inhibitors and novel GPCR agonist discovery
Lun K. Tsou et al.
SCIENTIFIC REPORTS (2020)
Paclitaxel and quercetin co-loaded functional mesoporous silica nanoparticles overcoming multidrug resistance in breast cancer
Mengyao Liu et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2020)
Fluorescent Mantle Carbon Coated Core-Shell SPIONs for Neuroengineering Applications
Ashish Tiwari et al.
ACS APPLIED BIO MATERIALS (2020)
Phytochemical-Based Nanomedicine for Advanced Cancer Theranostics: Perspectives on Clinical Trials to Clinical Use
Madhusmita Dhupal et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)
Core-shell nanostructures: perspectives towards drug delivery applications
Raj Kumar et al.
JOURNAL OF MATERIALS CHEMISTRY B (2020)
Nanoparticle-Based Drugs and Formulations: Current Status and Emerging Applications
Raj Kumar et al.
ACS APPLIED NANO MATERIALS (2020)
QSAR-Co: An Open Source Software for Developing Robust Multitasking or Multitarget Classification-Based QSAR Models
Pravin Ambure et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2019)
Applications of machine learning in drug discovery and development
Jessica Vamathevan et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery
Xin Yang et al.
CHEMICAL REVIEWS (2019)
DNA Damage and Associated DNA Repair Defects in Disease and Premature Aging
Vinod Tiwari et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2019)
Deep learning in drug discovery: opportunities, challenges and future prospects
Antonio Lavecchia
DRUG DISCOVERY TODAY (2019)
Artificial Intelligence for Drug Toxicity and Safety
Anna O. Basile et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
Recent advances and applications of machine learning in solid-state materials science
Jonathan Schmidt et al.
NPJ COMPUTATIONAL MATERIALS (2019)
Physiological and Pharmaceutical Considerations for Rectal Drug Formulations
Susan Hua
FRONTIERS IN PHARMACOLOGY (2019)
Computational methods and tools to predict cytochrome P450 metabolism for drug discovery
Jonathan D. Tyzack et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2019)
Fluorescent metal-doped carbon dots for neuronal manipulations
Vijay Bhooshan Kumar et al.
ULTRASONICS SONOCHEMISTRY (2019)
An overview of deep learning in medical imaging focusing on MRI
Alexander Selvikvag Lundervold et al.
ZEITSCHRIFT FUR MEDIZINISCHE PHYSIK (2019)
Generating Focused Molecule Libraries for Drug Discovery with Recurrent Neural Networks
Marwin H. S. Segler et al.
ACS CENTRAL SCIENCE (2018)
Importance of integrating nanotechnology with pharmacology and physiology for innovative drug delivery and therapy - an illustration with firsthand examples
Rui Xue Zhang et al.
ACTA PHARMACOLOGICA SINICA (2018)
Advancing Predictive Hepatotoxicity at the Intersection of Experimental, in Silico, and Artificial Intelligence Technologies
Keith Fraser et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2018)
Non-animal methods to predict skin sensitization (I): the Cosmetics Europe database
Sebastian Hoffmann et al.
CRITICAL REVIEWS IN TOXICOLOGY (2018)
Foreword: computational special focus issue
Cherif F. Matta et al.
FUTURE MEDICINAL CHEMISTRY (2018)
Trace metal metabolism in plants
Elisa Andresen et al.
JOURNAL OF EXPERIMENTAL BOTANY (2018)
Liposomal Drug Delivery Systems and Anticancer Drugs
Temidayo O. B. Olusanya et al.
MOLECULES (2018)
Combining machine learning models of in vitro and in vivo bioassays improves rat carcinogenicity prediction
Davy Guan et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2018)
Solid lipid nanoparticles for the controlled delivery of poorly water soluble non-steroidal anti-inflammatory drugs
Raj Kumar et al.
ULTRASONICS SONOCHEMISTRY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Anticancer Potential of Green Synthesized Silver Nanoparticles Using Extract of Nepeta deflersiana against Human Cervical Cancer Cells (HeLA)
Ebtesam S. Al-Sheddi et al.
BIOINORGANIC CHEMISTRY AND APPLICATIONS (2018)
Chitosan-Based Nanomaterials for Drug Delivery
Jianghua Li et al.
MOLECULES (2018)
Tumor Microenvironment Targeted Nanotherapy
Clara Fernandes et al.
FRONTIERS IN PHARMACOLOGY (2018)
Epigenetics of Modified DNA Bases: 5-Methylcytosine and Beyond
Suresh Kumar et al.
FRONTIERS IN GENETICS (2018)
Markers as mediators: A review and synthesis of epigenetics literature
Clemence Pinel et al.
BIOSOCIETIES (2018)
Detection of drug-drug interactions through data mining studies using clinical sources, scientific literature and social media
Santiago Vilar et al.
BRIEFINGS IN BIOINFORMATICS (2018)
Profiling Prediction of Kinase Inhibitors: Toward the Virtual Assay
Benjamin Merget et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
The ChEMBL database in 2017
Anna Gaulton et al.
NUCLEIC ACIDS RESEARCH (2017)
Demystifying Multitask Deep Neural Networks for Quantitative Structure-Activity Relationships
Yuting Xu et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2017)
Is Multitask Deep Learning Practical for Pharma?
Bharath Ramsundar et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2017)
Comparison of Deep Learning With Multiple Machine Learning Methods and Metrics Using Diverse Drug Discovery Data Sets
Alexandru Korotcov et al.
MOLECULAR PHARMACEUTICS (2017)
Deep-learning: investigating deep neural networks hyper-parameters and comparison of performance to shallow methods for modeling bioactivity data
Alexios Koutsoukas et al.
JOURNAL OF CHEMINFORMATICS (2017)
Beyond the hype: deep neural networks outperform established methods using a ChEMBL bioactivity benchmark set
Eelke B. Lenselink et al.
JOURNAL OF CHEMINFORMATICS (2017)
Chemical Space: Big Data Challenge for Molecular Diversity
Mahendra Awale et al.
CHIMIA (2017)
From machine learning to deep learning: progress in machine intelligence for rational drug discovery
Lu Zhang et al.
DRUG DISCOVERY TODAY (2017)
Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies
Giuseppa Pistritto et al.
AGING-US (2016)
Have artificial neural networks met expectations in drug discovery as implemented in QSAR framework?
Dimitar Dobchev et al.
EXPERT OPINION ON DRUG DISCOVERY (2016)
The Next Era: Deep Learning in Pharmaceutical Research
Sean Ekins
PHARMACEUTICAL RESEARCH (2016)
Epigenetic Determinants of Cancer
Stephen B. Baylin et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)
Drug Delivery Approaches for the Treatment of Cervical Cancer
Farideh Ordikhani et al.
PHARMACEUTICS (2016)
DeepTox: Toxicity Prediction using Deep Learning
Andreas Mayr et al.
FRONTIERS IN ENVIRONMENTAL SCIENCE (2016)
The effect of environmental chemicals on the tumor microenvironment
Stephanie C. Casey et al.
CARCINOGENESIS (2015)
The Bmi-1 helix-turn and ring finger domains are required for Bmi-1 antagonism of (-) epigallocatechin-3-gallate suppression of skin cancer cell survival
Sivaprakasam Balasubramanian et al.
CELLULAR SIGNALLING (2015)
In Silico Assessment of the Acute Toxicity of Chemicals: Recent Advances and New Model for Multitasking Prediction of Toxic Effect
Valeria V. Kleandrova et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2015)
Predicting drug metabolism: experiment and/or computation?
Johannes Kirchmair et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Plant Phytochemicals as Epigenetic Modulators: Role in Cancer Chemoprevention
Vijay S. Thakur et al.
AAPS JOURNAL (2014)
Nanomedicine to Overcome Cancer Multidrug Resistance
Xi Yang et al.
CURRENT DRUG METABOLISM (2014)
Structure-Based Virtual Screening for Drug Discovery: Principles, Applications and Recent Advances
Evanthia Lionta et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2014)
Antimutagenic compounds and their possible mechanisms of action
Karolina Sloczynska et al.
JOURNAL OF APPLIED GENETICS (2014)
The Effects of Lycopene on the Methylation of the GSTP1 Promoter and Global Methylation in Prostatic Cancer Cell Lines PC3 and LNCaP
Li-Juan Fu et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2014)
In vitro stimulation of calcium overload and apoptosis by sonodynamic therapy combined with hematoporphyrin monomethyl ether in C6 glioma cells
Shaochun Dai et al.
ONCOLOGY LETTERS (2014)
Computational Methods in Drug Discovery
Gregory Sliwoski et al.
PHARMACOLOGICAL REVIEWS (2014)
Carcinogenicity Prediction of Noncongeneric Chemicals by a Support Vector Machine
Min Zhong et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2013)
Dietary phytochemicals and cancer prevention: Nrf2 signaling, epigenetics, and cell death mechanisms in blocking cancer initiation and progression
Jong Hun Lee et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Predicting carcinogenicity of diverse chemicals using probabilistic neural network modeling approaches
Kunwar P. Singh et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
Green tea polyphenols causes cell cycle arrest and apoptosis in prostate cancer cells by suppressing class I histone deacetylases
Vijay S. Thakur et al.
CARCINOGENESIS (2012)
Epigenetic modifications in cancer
R. Kanwal et al.
CLINICAL GENETICS (2012)
From Virtual Screening to Bioactive Compounds by Visualizing and Clustering of Chemical Space
Alexander Klenner et al.
MOLECULAR INFORMATICS (2012)
Pharmacodynamics of curcumin as DNA hypomethylation agent in restoring the expression of Nrf2 via promoter CpGs demethylation
Tin Oo Khor et al.
BIOCHEMICAL PHARMACOLOGY (2011)
A Novel Prodrug of Epigallocatechin-3-gallate: Differential Epigenetic hTERT Repression in Human Breast Cancer Cells
Syed M. Meeran et al.
CANCER PREVENTION RESEARCH (2011)
Epigenetic Modifications Basic Mechanisms and Role in Cardiovascular Disease
Diane E. Handy et al.
CIRCULATION (2011)
Crocetin: an Agent Derived from Saffron for Prevention and Therapy for Cancer
William G. Gutheil et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
Epigenetic changes induced by curcumin and other natural compounds
Simone Reuter et al.
GENES AND NUTRITION (2011)
Apoptosis in cancer: from pathogenesis to treatment
Rebecca S. Y. Wong
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2011)
Early Identification and Management of Psychological Risk Factors (Yellow Flags) in Patients With Low Back Pain: A Reappraisal
Michael K. Nicholas et al.
PHYSICAL THERAPY (2011)
DNA methylation and soy phytoestrogens: quantitative study in DU-145 and PC-3 human prostate cancer cell lines
Mawussi Adjakly et al.
EPIGENOMICS (2011)
Resveratrol modulates the levels of microRNAs targeting genes encoding tumor-suppressors and effectors of TGFβ signaling pathway in SW480 cells
Esmerina Tili et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Regulation of Minichromosome Maintenance Gene Family by MicroRNA-1296 and Genistein in Prostate Cancer
Shahana Majid et al.
CANCER RESEARCH (2010)
Hypomethylation and induction of retinoic acid receptor beta 2 by concurrent action of adenosine analogues and natural compounds in breast cancer cells
Barbara Stefanska et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Curcumin induces down-regulation of EZH2 expression through the MAPK pathway in MDA-MB-435 human breast cancer cells
Wen-Feng Hua et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Epigallocatechin gallate up-regulation of miR-16 and induction of apoptosis in human cancer cells
Wing Pui Tsang et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2010)
Quantitative and qualitative models for carcinogenicity prediction for non-congeneric chemicals using CP ANN method for regulatory uses
Natalja Fjodorova et al.
MOLECULAR DIVERSITY (2010)
Curcumin reduces the expression of Bcl-2 by upregulating miR-15a and miR-16 in MCF-7 cells
Jie Yang et al.
MEDICAL ONCOLOGY (2010)
Sulforaphane Causes Epigenetic Repression of hTERT Expression in Human Breast Cancer Cell Lines
Syed M. Meeran et al.
PLOS ONE (2010)
The effect of dietary polyphenols on the epigenetic regulation of gene expression in MCF7 breast cancer cells
Jaroslaw Paluszczak et al.
TOXICOLOGY LETTERS (2010)
Curcumin is a potent DNA hypomethylation agent
Zhongfa Liu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Up-regulation of miR-200 and let-7 by Natural Agents Leads to the Reversal of Epithelial-to-Mesenchymal Transition in Gemcitabine-Resistant Pancreatic Cancer Cells
Yiwei Li et al.
CANCER RESEARCH (2009)
Nanoparticle-based targeted drug delivery
Rajesh Singh et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2009)
Epigenetic Modulation of the Retinoid X Receptor α by Green Tea in the Azoxymethane-ApcMin/+ Mouse Model of Intestinal Cancer
Suresh R. Volate et al.
MOLECULAR CARCINOGENESIS (2009)
Ellagitannin (BJA3121), an Anti-proliferative Natural Polyphenol Compound, can Regulate the Expression of MiRNAs in HepG(2) Cancer Cells
Xiao-Yun Wen et al.
PHYTOTHERAPY RESEARCH (2009)
Plant polyphenols as dietary antioxidants in human health and disease
Kanti Bhooshan Pandey et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2009)
Genistein induces the p21WAF1/CIP1 and p16INK4a tumor suppressor genes in prostate cancer cells by epigenetic mechanisms involving active chromatin modification
Shahana Majid et al.
CANCER RESEARCH (2008)
Modulation of gene methylation by genistein or lycopene in breast cancer cells
Audrey King-Batoon et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2008)
Conflicting views on chemical carcinogenesis arising from the design and evaluation of rodent carcinogenicity studies
Ronald L. Melnick et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2008)
Epigenetic and genetic mechanisms contribute to telomerase inhibition by EGCG
Joel B. Berletch et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells
Michael Sun et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Genistein down-regulates androgen receptor by modulating HDAC6-Hsp90 chaperone function
Shashwati Basak et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Curcumin, both histone deacetylase and p300/CBP-Specific inhibitor, represses the activity of nuclear factor kappa B and Notch 1 in Raji cells
Yan Chen et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2007)
Isoflavones at concentrations present in soy infant formula inhibit rotavirus infection in vitro
Aline Andres et al.
JOURNAL OF NUTRITION (2007)
The role of histone deacetylases (HDACs) in human cancer
Santiago Ropero et al.
MOLECULAR ONCOLOGY (2007)
In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
S. Ekins et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Dual action on promoter demethylation and chromatin by an isothiocyanate restored GSTP1 silenced in prostate cancer
L. G. Wang et al.
MOLECULAR CARCINOGENESIS (2007)
Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells
MC Myzak et al.
CARCINOGENESIS (2006)
Curcumin is an Inhibitor of p300 Histone Acetylatransferase
Monica G. Marcu et al.
MEDICINAL CHEMISTRY (2006)
Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids
WJ Lee et al.
MOLECULAR PHARMACOLOGY (2005)
Reversal of hypermethylation and reactivation of p16INK4a RARβ, and MGMT genes by genistein and other isoflavones from soy
MZ Fang et al.
CLINICAL CANCER RESEARCH (2005)
Transcriptome analysis of human colon Caco-2 cells exposed to sulforaphane
M Traka et al.
JOURNAL OF NUTRITION (2005)
Curcumin, a potent anti-tumor reagent, is a novel histone deacetylase inhibitor regulating B-NHL cell line Raji proliferation
HL Liu et al.
ACTA PHARMACOLOGICA SINICA (2005)
Curcumin-induced histone hypoacetylation: The role of reactive oxygen species
JH Kang et al.
BIOCHEMICAL PHARMACOLOGY (2005)
A novel mechanism of chemoprotection by sulforaphane: Inhibition of histone deacetylase
MC Myzak et al.
CANCER RESEARCH (2004)
Comparative analysis of topoisomerase IB inhibition and DNA intercalation by flavonoids and similar compounds: structural determinates of activity
MR Webb et al.
BIOCHEMICAL JOURNAL (2004)
Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription
K Balasubramanyam et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Share Paper
